
Zirus Antivirotics

Zirus
antivirotics, gene trap, H1N1, influenza, macrophage, Pandemic, Swine Flu, Vaccine, viral infection, Zirus, XVIVO
Scientists at Zirus are working on a new technology platform to cure and manage viral infection through the development of new classes of antivirotics. This animation depicts the life cycle of H1N1 influenza-A virus and the methodology Zirus uses to find appropriate targets.
Watch the NPR featured story on Zirus Antivirotics by Robert Krulwich.
“Few are as dedicated and diligent as the XVIVO team.”
Vice President, Management Supervisor, Ogilvy Healthworld